Valencia, Spain

Carles Ubeda

USPTO Granted Patents = 2 

Average Co-Inventor Count = 6.5

ph-index = 1

Forward Citations = 5(Granted Patents)


Company Filing History:


Years Active: 2018-2019

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Carles Ubeda: Innovator in Psoriatic Arthritis Treatment

Introduction

Carles Ubeda is a notable inventor based in Valencia, Spain. He has made significant contributions to the field of medical research, particularly in the treatment of psoriatic arthritis and rheumatoid arthritis. With a total of 2 patents, Ubeda's work is paving the way for advancements in therapeutic methods.

Latest Patents

Ubeda's latest patents include innovative methods for treating psoriatic arthritis. These patents encompass methods, agents, and compositions aimed at effectively managing this condition. Additionally, he has developed diagnostic methods related to rheumatoid arthritis. His work includes methods, reagents, and compositions for predicting the onset of rheumatoid arthritis in susceptible individuals, diagnosing its onset, and evaluating the efficacy of therapeutic regimens. Notably, he has identified specific bacterial species as biomarkers for these conditions.

Career Highlights

Throughout his career, Ubeda has worked with prestigious institutions such as New York University and Memorial Sloan Kettering Cancer Center. His research has focused on developing new therapeutic approaches and enhancing diagnostic capabilities in the field of rheumatology.

Collaborations

Ubeda has collaborated with esteemed colleagues, including Jose U Scher and Dan R Littman. These partnerships have further enriched his research and contributed to the advancement of medical science.

Conclusion

Carles Ubeda's innovative work in the treatment of psoriatic arthritis and rheumatoid arthritis highlights his commitment to improving patient outcomes. His contributions to medical research are invaluable and continue to inspire future advancements in the field.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…